Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Protalix BioTherapeutics (PLX) Receivables - Other (2019)

Protalix BioTherapeutics has reported Receivables - Other over the past 6 years, most recently at $26000.0 for Q4 2019.

  • Quarterly results put Receivables - Other at $26000.0 for Q4 2019, changed N/A from a year ago — trailing twelve months through Dec 2019 was $26000.0 (changed N/A YoY), and the annual figure for FY2019 was $26000.0, changed.
  • Receivables - Other for Q4 2019 was $26000.0 at Protalix BioTherapeutics, down from $2.6 million in the prior quarter.
  • Over the last five years, Receivables - Other for PLX hit a ceiling of $26000.0 in Q4 2019 and a floor of $26000.0 in Q4 2019.